Abstract: A method for regulating the structure and properties of the composite nanoabsorbent is provided. This method uses nanoporous chloromethylated polystyrene-divinylbenzene beads as the support material and adopts in situ precipitation method to load dissociative functional nanoparticles thereon; the composite nanoabsorbent of different absorption capacity and absorption speed can be prepared through regulating the pore structure, which is realized herein by means of starting crosslinking reactions through heating chloromethylated beads under existence of the swelling agent and the catalyst; through changing the proportions of different components in the reaction system, modes of heating and time of reaction, the polymer support with different pore structures can be prepared.

Abstract: A method for synthesizing poly(butylene succinate-co-butylene adipate) (PBSA), including: a) adding raw materials including succinic acid, adipic acid, and 1,4-butanediol into a reaction still; increasing the temperature in the reaction still to 130° C., and stiffing the raw materials, then keeping the temperature in the reaction still at 170-200° C., and dehydrating for 1-3 hours at atmospheric pressure, to yield an oligomer of PBSA; and b) decreasing the temperature of the reaction still to 100° C., and adding a composite catalyst system, the total addition of the composite catalyst system accounting for one ten-thousandth to one ten-millionth of a total weight percentage of the raw materials; uniformly stiffing and mixing the composite catalyst system and reactants, slowly vacuum pumping the reaction still, heating the reaction still to a temperature of 200-240° C. and allowing the composite catalyst system and the reactants to react for 10-20 hrs.

Abstract: A highly active supported bimetallic nanocatalyst and its preparation method is disclosed. During the preparation, using an ion exchange or adsorption resin bearing basic functional groups as the support of the said catalyst, successively introducing the first metal precursor FeCl4? and the second metal precursor (PdCl42?, NiCl42? or CuCl42?) onto the resin through ion exchange process; then under the protection of nitrogen gas, simultaneously reducing the two metals with either NaBH4 or KBH4; washing the resulting material with deoxygenated water and drying it, and the said catalyst is therefore obtained. The supported bimetallic material is characteristic of independent distribution of the two metals within the support. The independently distributed structure of the two metals enhances the catalytic efficiency of the second metal and the catalytic stability.

Abstract: A technological method for synthesizing optically pure L-/D-lactide by using a biogenic guanidine catalysis method. The method of the present invention comprises: by using biogenic guanidine creatinine (CR) as a catalyst and L-/D-lactic acid (90% of mass content) as a raw material, synthesizing optically pure L-/D-lactide by using a reactive reduced pressure distillation catalysis method.

Abstract: A method for treatment of dye wastewater by using ultraviolet-acetylacetone oxidation process is provided. This method belongs to the field of dye wastewater treatment, comprising the following steps: A) adding acetylacetone into dye-containing water, stirring and mixing them completely; B) putting the liquid obtained in step A) under ultraviolet irradiation till it is effectively decolorized. Provided is a new method for decolorizing high-concentrated dye wastewater on the basis of ultraviolet-induced oxidation process of phydroxyl radicals. This method can realize complete decolorization of the dye wastewater. During the oxidation process, the dye in the wastewater acts as the photosensitizer and can accelerate the decolorization process as the reaction progresses. The method can also improve BOD5/COD ratio from lower than 0.1 to higher than 0.3, which means that this method can be used not only for high-efficient decolorization of dye wastewater, but also as a preliminary step of microorganism treatment.

Abstract: A method for regulating the distribution of metallic nanoparticles within the resin support is provided. This method uses the ion exchange or absorption resin bearing basic functional groups as the support; firstly introducing the metal in the form of anionic complexes onto the resin support through the ion exchange process, then realizing the purpose of regulating the distribution of the metal and its compound within the resin support by means of changing the concentration of the reductive or deposition agent in water solution and the reaction time. The regulated distribution of metallic nanoparticles within the resin support is in the form of rings with different depths and densities.

Abstract: Disclosed is a high molecular weight polylactic acid synthesized by using a method for synthesizing and catalytically-polycondensing bionic creatinine-guanidinium chloride. Creatinine is used as the material in a reaction with aqueous hydrochloric acid to synthesize a bionic creatinine-guanidinium salt catalyst, creatinine-guanidinium chloride (CR.Cl). The creatinine-guanidinium chloride synthesized is used as a catalyst, an industrial grade lactic acid (LA, 85% to 90%, aqueous solution) is used as a monomer, a solvent-free two-step polycondensation method is used to synthesize and afford metal-free and toxic residue-free polylactic acid featuring high biological safety and high molecular weight.

Abstract: A method for synthesizing a medical grade biodegradable material, poly(lactic-co-glycolic acid), copolycondensation of lactic acid and glycolic acid catalyzed by biomass creatinine. The present invention uses commercialized creatinine (a type of biomaterial organic guanidine compounds—the arginine metabolite creatinine (CR) in human body) as the catalyst and industrial lactic acid (LA, mass content 85%, aqueous solution) and glycolic acid (GA, 95%) as the monomer to synthesize the high biosafety of medical poly(lactic-co-glycolic acid) in terms of two steps polycondensation without solvent.

Abstract: The present invention discloses a method for advanced treatment of bio-treated coking wastewater, belonging to the field of advanced treatment and recycled use of wastewater. It adopts polymeric ferric sulfate (PFS) and polyacrylamide (PAM) as the flocculant for pre-treatment of bio-treated effluent. After the process of precipitation and filtration, the effluent is guided through an adsorption column filled with environmentally-friendly nano-composites whereby the advanced treatment of the bio-treated coking wastewater is achieved. When the absorption process reaches the breakthrough point, the adsorption operation will be stopped and sodium hydroxide solution is used as the desorption reagent for regenerating the nano-composites; the high-concentrated component of the desorption liquid is sent out for incineration or production of coal water slurry, meanwhile the low-concentrated component of the desorption liquid is used to prepare sodium hydroxid solution for the adsorption process of the next batch.

Abstract: A method for treatment of dye wastewater by using ultraviolet-acetylacetone oxidation process is provided. This method belongs to the field of dye wastewater treatment, comprising the following steps: A) adding acetylacetone into dye-containing water, stirring and mixing them completely; B) putting the liquid obtained in step A) under ultraviolet irradiation till it is effectively decolorized. Provided is a new method for decolorizing high-concentrated dye wastewater on the basis of ultraviolet-induced oxidation process of phydroxyl radicals. This method can realize complete decolorization of the dye wastewater. During the oxidation process, the dye in the wastewater acts as the photosensitizer and can accelerate the decolorization process as the reaction progresses. The method can also improve BOD5/COD ratio from lower than 0.1 to higher than 0.3, which means that this method can be used not only for high-efficient decolorization of dye wastewater, but also as a preliminary step of microorganism treatment.

Abstract: A direct polycondensation method for medical biodegradable polylactic acid (PLA). The invention uses commercialized creatinine (a type of biomaterial organic guanidine compounds—the arginine metabolite creatinine in human body) as the catalyst and industrial lactic acid (mass content 85-90%, aqueous solution) as the monomer to synthesize the PLA in terms of second polycondensation without solvent. Instead of tin catalysts having cytotoxicity, the catalyst used in the invention has high biocompatibility and biosafety. The synthesized PLA does not contain any metal and other toxic components; therefore, it can be used as the carrier for targeting drugs and controlled release drugs. The green catalyst and green processing method (no solvent applied and no toxic products produced) are used to synthesize the green biodegradable PLA with high biosafety. The molecular weight distribution for all synthesized products is narrow and the molecular weight is controllable within 1.5-3.0×104.

Abstract: A highly active supported bimetallic nanocatalyst and its preparation method is disclosed. During the preparation, using an ion exchange or absorption resin bearing basic functional groups as the support of the said catalyst, successively introducing the first metal precursor FeCl4? and the second metal precursor (PdCl42?, NiCl42? or CuCl42?) onto the resin through ion exchange process; then under the protection of nitrogen gas, simultaneously reducing the two metals with either NaBH4 or KBH4; washing the material with deoxygenated water and drying it, and the said catalyst is therefore obtained. The supported bimetallic material is characteristic of independent distribution of the two metals within the support. The independently distributed structure of the two metals enhances the catalytic efficiency of the second metal and the catalytic stability.

Abstract: A method for synthesizing a medical grade biodegradable material, poly(lactic-co-glycolic acid), copolycondensation of lactic acid and glycolic acid catalyzed by biomass creatinine. The present invention uses commercialized creatinine (a type of biomaterial organic guanidine compounds—the arginine metabolite creatinine (CR) in human body) as the catalyst and industrial lactic acid (LA, mass content 85%, aqueous solution) and glycolic acid (GA, 95%) as the monomer to synthesize the high biosafety of medical poly(lactic-co-glycolic acid) in terms of two steps polycondensation without solvent.

Abstract: Disclosed is a high molecular weight polylactic acid synthesized by using a method for synthesizing and catalytically-polycondensing bionic creatinine-guanidinium chloride. Creatinine is used as the material in a reaction with aqueous hydrochloric acid to synthesize a bionic creatinine-guanidinium salt catalyst, creatinine-guanidinium chloride (CR.Cl). The creatinine-guanidinium chloride synthesized is used as a catalyst, an industrial grade lactic acid (LA, 85% to 90%, aqueous solution) is used as a monomer, a solvent-free two-step polycondensation method is used to synthesize and afford metal-free and toxic residue-free polylactic acid featuring high biological safety and high molecular weight.

Abstract: A method for regulating the structure and properties of the composite nanoabsorbent is provided. This method uses nanoporous chloromethylated polystyrene-divinylbenzene beads as the support material and adopts in situ precipitation method to load dissociative functional nanoparticles thereon; the composite nanoabsorbent of different absorption capacity and absorption speed can be prepared through regulating the pore structure, which is realized herein by means of starting crosslinking reactions through heating chloromethylated beads under existence of the swelling agent and the catalyst; through changing the proportions of different components in the reaction system, modes of heating and time of reaction, the polymer support with different pore structures can be prepared.

Abstract: A deep purification method for removing trace thallium in water by using polymer-based nanosized manganese oxide is disclosed. This method comprising the following steps: adjusting the pH value of the water polluted with trace thallium to 5-8.5 and filtering it, then channeling the water so treated through a packed tower of filtering bed packed with polymer-based nanosized manganese oxide so that the thallium in water can be selectively adsorbed upon the nanocomposite material, stopping the adsorption process when the thallium in water reaches the leak point, and then using mixed solution of HCl—Ca(NO3)2 or NaOH—NaClO as the desorption agent and starting desorption and regeneration process for the packing material of polymer-based nanosized manganese oxide. This effectively reduces the concentration of thallium in water from 0.01-0.5 mg/L to lower than 0.1 ?g/L, despite the much higher concentration of coexisting competitive cations such as Ca2+, Mg2+, Na+ and Si(IV).

Abstract: A method for regulating the distribution of metallic nanoparticles within the resin support is provided. This method uses the ion exchange or absorption resin bearing basic functional groups as the support; firstly introducing the metal in the form of anionic complexes onto the resin support through the ion exchange process, then realizing the purpose of regulating the distribution of the metal and its compound within the resin support by means of changing the concentration of the reductive or deposition agent in water solution and the reaction time. The regulated distribution of metallic nanoparticles within the resin support is in the form of rings with different depths and densities.

Abstract: The present invention provides a direct polycondensation method for medical biodegradable polylactic acid (PLA) using creatinine catalyzed lactic acid. The invention uses commercialized creatinine (a type of biomaterial organic guanidine compounds—the arginine metabolite creatinine (CR) in human body) as the catalyst and industrial lactic acid (LA, mass content 85-90%, aqueous solution) as the monomer to synthesize the high biosafety of medical PLA in terms of second polycondensation without solvent (identity). Instead of tin catalysts having cytotoxicity, the catalyst used in the invention has high biocompatibility and biosafety. The synthesized PLA does not contain any metal and other toxic components; therefore, it can be used as the carrier for targeting drugs and controlled release drugs. In addition, the green catalyst and green processing method (no solvent applied and no toxic products produced) are used in the invention to synthesize the green biodegradable PLA with high biosafety.

Abstract: The invention discloses a novel method for trace phosphate removal from water by using a composite resin. Firstly, adjusting the pH value of the raw water to 5.0˜9.0 and prefiltering the water, then leading the filtrate through an absorption tower packed with the composite resin, the trace phosphate in the water is therefore absorbed onto the composite resin; stopping the absorption run when it reaches the leakage point, using a binary NaOH-NaCl solution as the regenerant of the exhausted sorbent, followed by rinsing the composite resin-filled absorption tower with saturated carbon dioxide solution to regenerate the resin. In this invention, a composite resin with nanosized hydrated ferric oxide (HFO) or hydrous manganese dioxide (HMO) particles loaded on its surface is adopted as the absorbent for enhanced phosphate removal from water. A significant decrease of phosphate content in the effluent from this treatment system is found from 0.